# Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

> **NCT05526729** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 222 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **OTHER:** Beovu

## Key facts

- **NCT ID:** NCT05526729
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-02
- **Primary completion:** 2024-06-29
- **Final completion:** 2024-06-29
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526729, "Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05526729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*